speb/financial-data huggingface dataset:
AAL balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 26112000000.00
AAL income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 658880000.00
AAL income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.72
AAL income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -473000000.00
AAL income_statement (quarterly, 2025-03-31) — EBIT: -220000000.00
AAL income_statement (quarterly, 2025-03-31) — EBITDA: -220000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 1869000000.00
AAL cash_flow (quarterly, 2025-03-31) — End Cash Position: 931000000.00
AAL cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1223000000.00
AAL cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1632000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -4547000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Goodwill: 4091000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 6133000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Gross PPE: 62549000000.00
AAL income_statement (quarterly, 2025-03-31) — Gross Profit: 1878000000.00
AAL cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 4000000.00
AAL income_statement (quarterly, 2025-03-31) — Interest Expense: 428000000.00
AAL income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 428000000.00
AAL income_statement (quarterly, 2025-03-31) — Interest Income: 94000000.00
AAL income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 94000000.00
AAL cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 524000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Inventory: 2653000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 24934000000.00
AAL cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1204000000.00
AAL cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 325000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 10306000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 6062000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 24713000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 30775000000.00
AAL cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 325000000.00
AAL cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1362000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Net Debt: 28607000000.00
AAL income_statement (quarterly, 2025-03-31) — Net Income: -473000000.00
AAL income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -473000000.00
AAL income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -473000000.00
AAL income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -473000000.00
AAL income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -473000000.00
AAL income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -473000000.00
AAL income_statement (quarterly, 2025-03-31) — Net Interest Income: -334000000.00
AAL cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -457000000.00
AAL cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -1037000000.00
AAL cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -1037000000.00
AAL income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -334000000.00
AAL cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -186000000.00
AAL cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 77000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Net PPE: 38757000000.00
AAL cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -74000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -10641000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 2655000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 6708000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 6708000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 2655000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1869000000.00
AAL income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -150000000.00
AAL income_statement (quarterly, 2025-03-31) — Normalized Income: -421904320.99
AAL cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 2456000000.00
AAL income_statement (quarterly, 2025-03-31) — Operating Income: -200000000.00
AAL income_statement (quarterly, 2025-03-31) — Operating Revenue: 11580000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 659481003.00
AAL balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 909000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 4729000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -4547000000.00
AAL income_statement (quarterly, 2025-03-31) — Other Income Expense: -114000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2042000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1461000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1653000000.00
AAL income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -44000000.00
AAL income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1628000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Other Properties: 7442000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 6631000000.00
AAL income_statement (quarterly, 2025-03-31) — Other Special Charges: 70000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Payables: 3114000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 7692000000.00
AAL income_statement (quarterly, 2025-03-31) — Pretax Income: -648000000.00
AAL cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1806000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Receivables: 1928000000.00
AAL income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 10673000000.00
AAL income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 1125000000.00
AAL cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1362000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 647000000.00
AAL income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 4000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -7316000000.00
AAL cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 1349000000.00
AAL income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 450000000.00
AAL income_statement (quarterly, 2025-03-31) — Selling General And Administration: 450000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Share Issued: 659481003.00
AAL cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -74000000.00
AAL income_statement (quarterly, 2025-03-31) — Special Income Charges: -70000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -4508000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -10641000000.00
AAL income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -18904320.99
AAL income_statement (quarterly, 2025-03-31) — Tax Provision: -175000000.00
AAL income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
AAL balance_sheet (quarterly, 2025-03-31) — Total Assets: 62609000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 20205000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Total Debt: 36600000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -4508000000.00
AAL income_statement (quarterly, 2025-03-31) — Total Expenses: 12751000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 67117000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 49006000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 41005000000.00
AAL income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -270000000.00
AAL income_statement (quarterly, 2025-03-31) — Total Unusual Items: -70000000.00
AAL income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -70000000.00
AAL balance_sheet (quarterly, 2025-03-31) — Working Capital: -12509000000.00
AAL income_statement (quarterly, 2025-06-30) — +Operating Expense: 2234000000.00
AAL income_statement (quarterly, 2025-06-30) — +Total Revenue: 14392000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3130000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2057000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -24298000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 7370000000.00
AAL income_statement (quarterly, 2025-06-30) — Basic Average Shares: 660127000.00
AAL income_statement (quarterly, 2025-06-30) — Basic EPS: 0.91
AAL cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 931000000.00
AAL cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -499000000.00
AAL cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -499000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 7320000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 7000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 833000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 8573000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Cash Financial: 833000000.00
AAL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 311000000.00
AAL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1274000000.00
AAL cash_flow (quarterly, 2025-06-30) — Changes In Cash: 0.00
AAL balance_sheet (quarterly, 2025-06-30) — Common Stock: 7000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -3870000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 976000000.00
AAL income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 10976000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 5010000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Current Assets: 15068000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1120000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Current Debt: 4605000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 5725000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 11906000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 11906000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 25771000000.00
AAL income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 660367000.00
AAL income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.91
AAL income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 599000000.00
AAL income_statement (quarterly, 2025-06-30) — EBIT: 1271000000.00
AAL income_statement (quarterly, 2025-06-30) — EBITDA: 1271000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 1814000000.00
AAL cash_flow (quarterly, 2025-06-30) — End Cash Position: 931000000.00
AAL cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 311000000.00
AAL cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 464000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -4530000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Goodwill: 4091000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 6131000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Gross PPE: 62987000000.00
AAL income_statement (quarterly, 2025-06-30) — Gross Profit: 3416000000.00
AAL cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 6000000.00
AAL income_statement (quarterly, 2025-06-30) — Interest Expense: 433000000.00
AAL income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 433000000.00
AAL income_statement (quarterly, 2025-06-30) — Interest Income: 100000000.00
AAL income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 100000000.00
AAL cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 308000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Inventory: 2776000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 26011000000.00
AAL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1274000000.00
AAL cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 1334000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 10304000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 6200000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 25276000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 31476000000.00
AAL cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 1334000000.00
AAL cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1003000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Net Debt: 29048000000.00
AAL income_statement (quarterly, 2025-06-30) — Net Income: 599000000.00
AAL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 599000000.00
AAL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 599000000.00
AAL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 599000000.00
AAL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 599000000.00
AAL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 599000000.00
AAL income_statement (quarterly, 2025-06-30) — Net Interest Income: -333000000.00
AAL cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -1104000000.00
AAL cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 331000000.00
AAL cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 331000000.00
AAL income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -333000000.00
AAL cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -20000000.00
AAL cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 129000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Net PPE: 38689000000.00
AAL cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 0.00
AAL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -10001000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 2411000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 6805000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 6805000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 2411000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 1814000000.00
AAL income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1318000000.00
AAL income_statement (quarterly, 2025-06-30) — Normalized Income: 632595465.39
AAL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 963000000.00
AAL income_statement (quarterly, 2025-06-30) — Operating Income: 1182000000.00
AAL income_statement (quarterly, 2025-06-30) — Operating Revenue: 13334000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 659797256.00
AAL balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 855000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 4605000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -4530000000.00
AAL income_statement (quarterly, 2025-06-30) — Other Income Expense: -11000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2040000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1368000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1671000000.00
AAL income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 36000000.00
AAL income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1699000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Other Properties: 7488000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 7740000000.00
AAL income_statement (quarterly, 2025-06-30) — Other Special Charges: 47000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Payables: 3130000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 8140000000.00
AAL income_statement (quarterly, 2025-06-30) — Pretax Income: 838000000.00
AAL cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -2874000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Receivables: 2057000000.00
AAL income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 10976000000.00
AAL income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 1199000000.00
AAL cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1003000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 807000000.00
AAL income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
AAL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -6717000000.00
AAL cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 1770000000.00
AAL income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 535000000.00
AAL income_statement (quarterly, 2025-06-30) — Selling General And Administration: 535000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Share Issued: 659797256.00
AAL cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: 0.00
AAL income_statement (quarterly, 2025-06-30) — Special Income Charges: -47000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -3870000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -10001000000.00
AAL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -13404534.61
AAL income_statement (quarterly, 2025-06-30) — Tax Provision: 239000000.00
AAL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.29
AAL balance_sheet (quarterly, 2025-06-30) — Total Assets: 63667000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 21406000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Total Debt: 37201000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -3870000000.00
AAL income_statement (quarterly, 2025-06-30) — Total Expenses: 13210000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 67537000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 48599000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 41766000000.00
AAL income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1135000000.00
AAL income_statement (quarterly, 2025-06-30) — Total Unusual Items: -47000000.00
AAL income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -47000000.00
AAL balance_sheet (quarterly, 2025-06-30) — Working Capital: -10703000000.00
AAL income_statement (quarterly, 2025-09-30) — +Operating Expense: 2217000000.00
AAL income_statement (quarterly, 2025-09-30) — +Total Revenue: 13691000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2833000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2028000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -24752000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7377000000.00
AAL income_statement (quarterly, 2025-09-30) — Basic Average Shares: 660358000.00
AAL income_statement (quarterly, 2025-09-30) — Basic EPS: -0.17
AAL cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 931000000.00
AAL cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -826000000.00
AAL cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -826000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 7347000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Capital Stock: 7000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 835000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 6858000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Cash Financial: 835000000.00
AAL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -921000000.00
AAL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 974000000.00
AAL cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Common Stock: 7000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -3962000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 850000000.00
AAL income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 11316000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 5267000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Current Assets: 13250000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1143000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Current Debt: 3604000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4747000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 11791000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 11791000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 24638000000.00
AAL income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 660358000.00
AAL income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.17
AAL income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -114000000.00
AAL income_statement (quarterly, 2025-09-30) — EBIT: 290000000.00
AAL income_statement (quarterly, 2025-09-30) — EBITDA: 290000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 1759000000.00
AAL cash_flow (quarterly, 2025-09-30) — End Cash Position: 938000000.00
AAL cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -921000000.00
AAL cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -872000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -4515000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Goodwill: 4091000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 6129000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Gross PPE: 63705000000.00
AAL income_statement (quarterly, 2025-09-30) — Gross Profit: 2375000000.00
AAL cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 3000000.00
AAL income_statement (quarterly, 2025-09-30) — Interest Expense: 432000000.00
AAL income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 432000000.00
AAL income_statement (quarterly, 2025-09-30) — Interest Income: 90000000.00
AAL income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 90000000.00
AAL cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 492000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Inventory: 2782000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Invested Capital: 24755000000.00
AAL cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 974000000.00
AAL cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 510000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 10366000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 6204000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 25113000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 31317000000.00
AAL cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 510000000.00
AAL cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1722000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Net Debt: 27882000000.00
AAL income_statement (quarterly, 2025-09-30) — Net Income: -114000000.00
AAL income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -114000000.00
AAL income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -114000000.00
AAL income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -114000000.00
AAL income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -114000000.00
AAL income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -114000000.00
AAL income_statement (quarterly, 2025-09-30) — Net Interest Income: -342000000.00
AAL cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 1704000000.00
AAL cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1138000000.00
AAL cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1212000000.00
AAL income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -342000000.00
AAL cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 217000000.00
AAL cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 53000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Net PPE: 38953000000.00
AAL cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 43000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -10091000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 2435000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 6815000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 6815000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 2435000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 1759000000.00
AAL income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 297000000.00
AAL income_statement (quarterly, 2025-09-30) — Normalized Income: -108380281.69
AAL cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -46000000.00
AAL income_statement (quarterly, 2025-09-30) — Operating Income: 158000000.00
AAL income_statement (quarterly, 2025-09-30) — Operating Revenue: 12683000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 660064930.00
AAL balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 822000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 3604000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -4515000000.00
AAL income_statement (quarterly, 2025-09-30) — Other Income Expense: 42000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2038000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1374000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1574000000.00
AAL income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 49000000.00
AAL income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1734000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Other Properties: 7495000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 6023000000.00
AAL income_statement (quarterly, 2025-09-30) — Other Special Charges: 4000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Payables: 2833000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 8100000000.00
AAL income_statement (quarterly, 2025-09-30) — Pretax Income: -142000000.00
AAL cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -121000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Receivables: 2028000000.00
AAL income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 11316000000.00
AAL income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 1218000000.00
AAL cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1648000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 760000000.00
AAL income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 3000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -6831000000.00
AAL cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 1825000000.00
AAL cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 43000000.00
AAL income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 483000000.00
AAL income_statement (quarterly, 2025-09-30) — Selling General And Administration: 483000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Share Issued: 660064930.00
AAL income_statement (quarterly, 2025-09-30) — Special Income Charges: -7000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -3962000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -10091000000.00
AAL income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1380281.69
AAL income_statement (quarterly, 2025-09-30) — Tax Provision: -28000000.00
AAL income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.20
AAL balance_sheet (quarterly, 2025-09-30) — Total Assets: 62141000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 21151000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Total Debt: 36064000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -3962000000.00
AAL income_statement (quarterly, 2025-09-30) — Total Expenses: 13533000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 66103000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 48891000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 41465000000.00
AAL income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 151000000.00
AAL income_statement (quarterly, 2025-09-30) — Total Unusual Items: -7000000.00
AAL income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -7000000.00
AAL balance_sheet (quarterly, 2025-09-30) — Working Capital: -11388000000.00
AAL income_statement (annual, 2025-12-31) — +Operating Expense: 8845000000.00
AAL income_statement (quarterly, 2025-12-31) — +Operating Expense: 2317000000.00
AAL income_statement (annual, 2025-12-31) — +Total Revenue: 54633000000.00
AAL income_statement (quarterly, 2025-12-31) — +Total Revenue: 13999000000.00
AAL balance_sheet (annual, 2025-12-31) — Accounts Payable: 2840000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2840000000.00
AAL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2075000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2075000000.00
AAL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -25192000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -25192000000.00
AAL balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 7387000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7387000000.00
AAL income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
AAL income_statement (annual, 2025-12-31) — Basic Average Shares: 659964000.00
AAL income_statement (quarterly, 2025-12-31) — Basic Average Shares: 660492000.00
AAL income_statement (annual, 2025-12-31) — Basic EPS: 0.17
AAL income_statement (quarterly, 2025-12-31) — Basic EPS: 0.15
AAL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 902000000.00
AAL cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 938000000.00
AAL cash_flow (annual, 2025-12-31) — Capital Expenditure: -3779000000.00
AAL cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1567000000.00
AAL cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -3779000000.00
AAL cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -1567000000.00
AAL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 7690000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 7690000000.00
AAL balance_sheet (annual, 2025-12-31) — Capital Stock: 7000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 7000000.00
AAL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 954000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 954000000.00
AAL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5836000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5836000000.00
AAL balance_sheet (annual, 2025-12-31) — Cash Financial: 954000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Cash Financial: 954000000.00
AAL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1051000000.00
AAL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1880000000.00
AAL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1894000000.00
AAL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -328000000.00
AAL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3099000000.00
AAL cash_flow (annual, 2025-12-31) — Change In Account Payable: 335000000.00
AAL cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -218000000.00
AAL cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 421000000.00
AAL cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 510000000.00
AAL cash_flow (annual, 2025-12-31) — Change In Payable: 335000000.00
AAL cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 335000000.00
AAL cash_flow (annual, 2025-12-31) — Change In Receivables: -74000000.00
AAL cash_flow (annual, 2025-12-31) — Change In Working Capital: 974000000.00
AAL cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -74000000.00
AAL cash_flow (annual, 2025-12-31) — Changes In Cash: 154000000.00
AAL cash_flow (quarterly, 2025-12-31) — Changes In Cash: 109000000.00
AAL balance_sheet (annual, 2025-12-31) — Common Stock: 7000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Common Stock: 7000000.00
AAL balance_sheet (annual, 2025-12-31) — Common Stock Equity: -3727000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -3727000000.00
AAL balance_sheet (annual, 2025-12-31) — Construction In Progress: 656000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 656000000.00
AAL income_statement (annual, 2025-12-31) — Cost Of Revenue: 44162000000.00
AAL income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 11196000000.00
AAL balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 5044000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 5044000000.00
AAL balance_sheet (annual, 2025-12-31) — Current Assets: 12205000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Current Assets: 12205000000.00
AAL balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1175000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1175000000.00
AAL balance_sheet (annual, 2025-12-31) — Current Debt: 4555000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Current Debt: 4555000000.00
AAL balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5730000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5730000000.00
AAL balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 10883000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 10883000000.00
AAL balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 10883000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 10883000000.00
AAL balance_sheet (annual, 2025-12-31) — Current Liabilities: 24492000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 24492000000.00
AAL cash_flow (annual, 2025-12-31) — Deferred Income Tax: 79000000.00
AAL cash_flow (annual, 2025-12-31) — Deferred Tax: 79000000.00
AAL cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2219000000.00
AAL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2219000000.00
AAL income_statement (annual, 2025-12-31) — Diluted Average Shares: 659964000.00
AAL income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 661856000.00
AAL income_statement (annual, 2025-12-31) — Diluted EPS: 0.17
AAL income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.15
AAL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 111000000.00
AAL income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 99000000.00
AAL income_statement (annual, 2025-12-31) — EBIT: 1906000000.00
AAL income_statement (quarterly, 2025-12-31) — EBIT: 564000000.00
AAL income_statement (annual, 2025-12-31) — EBITDA: 4125000000.00
AAL income_statement (quarterly, 2025-12-31) — EBITDA: 564000000.00
AAL balance_sheet (annual, 2025-12-31) — Employee Benefits: 1568000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1568000000.00
AAL cash_flow (annual, 2025-12-31) — End Cash Position: 1056000000.00
AAL cash_flow (quarterly, 2025-12-31) — End Cash Position: 1038000000.00
AAL cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1051000000.00
AAL cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1880000000.00
AAL cash_flow (annual, 2025-12-31) — Free Cash Flow: -680000000.00
AAL cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -3010000000.00
AAL income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 0.00
AAL balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -4389000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -4389000000.00
AAL balance_sheet (annual, 2025-12-31) — Goodwill: 4091000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Goodwill: 4091000000.00
AAL balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 6157000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 6157000000.00
AAL balance_sheet (annual, 2025-12-31) — Gross PPE: 64823000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Gross PPE: 64823000000.00
AAL income_statement (annual, 2025-12-31) — Gross Profit: 10471000000.00
AAL income_statement (quarterly, 2025-12-31) — Gross Profit: 2803000000.00
AAL income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
AAL income_statement (annual, 2025-12-31) — Interest Expense: 1716000000.00
AAL income_statement (quarterly, 2025-12-31) — Interest Expense: 422000000.00
AAL income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1716000000.00
AAL income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 422000000.00
AAL income_statement (annual, 2025-12-31) — Interest Income: 357000000.00
AAL income_statement (quarterly, 2025-12-31) — Interest Income: 72000000.00
AAL income_statement (annual, 2025-12-31) — Interest Income Non Operating: 357000000.00
AAL income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 72000000.00
AAL cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1696000000.00
AAL balance_sheet (annual, 2025-12-31) — Inventory: 2792000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Inventory: 2792000000.00
AAL balance_sheet (annual, 2025-12-31) — Invested Capital: 25467000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Invested Capital: 25467000000.00
AAL cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1894000000.00
AAL cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -328000000.00
AAL cash_flow (annual, 2025-12-31) — Issuance Of Debt: 4613000000.00
AAL cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2444000000.00
AAL balance_sheet (annual, 2025-12-31) — Land And Improvements: 10479000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 10479000000.00
AAL balance_sheet (annual, 2025-12-31) — Line Of Credit: 914000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 914000000.00
AAL balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 6515000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 6515000000.00
AAL balance_sheet (annual, 2025-12-31) — Long Term Debt: 24639000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 24639000000.00
AAL balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 31154000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 31154000000.00
AAL cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3773000000.00
AAL cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 1604000000.00
AAL cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -5504000000.00
AAL cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -416000000.00
AAL balance_sheet (annual, 2025-12-31) — Net Debt: 28240000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Net Debt: 28240000000.00
AAL income_statement (annual, 2025-12-31) — Net Income: 111000000.00
AAL income_statement (quarterly, 2025-12-31) — Net Income: 99000000.00
AAL income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 111000000.00
AAL income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 99000000.00
AAL income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 111000000.00
AAL income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 99000000.00
AAL income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 111000000.00
AAL income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 99000000.00
AAL income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 111000000.00
AAL income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 99000000.00
AAL cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 111000000.00
AAL income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 111000000.00
AAL income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 99000000.00
AAL income_statement (annual, 2025-12-31) — Net Interest Income: -1359000000.00
AAL income_statement (quarterly, 2025-12-31) — Net Interest Income: -350000000.00
AAL cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 1284000000.00
AAL cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 1144000000.00
AAL cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -891000000.00
AAL cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 2028000000.00
AAL cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -1731000000.00
AAL cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 1188000000.00
AAL income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1359000000.00
AAL income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -350000000.00
AAL cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -160000000.00
AAL cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -148000000.00
AAL cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 257000000.00
AAL cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -5000000.00
AAL balance_sheet (annual, 2025-12-31) — Net PPE: 39631000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Net PPE: 39631000000.00
AAL cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 344000000.00
AAL cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 100000000.00
AAL cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 840000000.00
AAL balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -9884000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -9884000000.00
AAL balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 2368000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 2368000000.00
AAL balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 6839000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 6839000000.00
AAL balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 6839000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 6839000000.00
AAL balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 2368000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 2368000000.00
AAL balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1568000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1568000000.00
AAL income_statement (annual, 2025-12-31) — Normalized EBITDA: 4284000000.00
AAL income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 598000000.00
AAL income_statement (annual, 2025-12-31) — Normalized Income: 236610000.00
AAL income_statement (quarterly, 2025-12-31) — Normalized Income: 122704225.35
AAL cash_flow (annual, 2025-12-31) — Operating Cash Flow: 3099000000.00
AAL cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1443000000.00
AAL cash_flow (annual, 2025-12-31) — Operating Gains Losses: -11000000.00
AAL income_statement (annual, 2025-12-31) — Operating Income: 1626000000.00
AAL income_statement (quarterly, 2025-12-31) — Operating Income: 486000000.00
AAL income_statement (annual, 2025-12-31) — Operating Revenue: 50482000000.00
AAL income_statement (quarterly, 2025-12-31) — Operating Revenue: 12885000000.00
AAL balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 660301080.00
AAL balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 660301080.00
AAL balance_sheet (annual, 2025-12-31) — Other Current Assets: 767000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 767000000.00
AAL balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 3641000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 3641000000.00
AAL balance_sheet (annual, 2025-12-31) — Other Current Liabilities: -5000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: -5000000.00
AAL balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -4389000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -4389000000.00
AAL income_statement (annual, 2025-12-31) — Other Income Expense: -77000000.00
AAL income_statement (quarterly, 2025-12-31) — Other Income Expense: 6000000.00
AAL balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 2066000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 2066000000.00
AAL cash_flow (annual, 2025-12-31) — Other Non Cash Items: -330000000.00
AAL balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1413000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1413000000.00
AAL balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1448000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1448000000.00
AAL income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 82000000.00
AAL income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 40000000.00
AAL income_statement (annual, 2025-12-31) — Other Operating Expenses: 6848000000.00
AAL income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1787000000.00